THYROID (ISSN 1050-7256) is a prestigious international peer-reviewed journal published monthly by Mary Ann Liebert, Inc. in the United States, serving as a leading venue for high-quality original research, reviews, and clinical guidelines in the field of thyroidology. The journal encompasses a broad spectrum of thyroid-related topics, including the diagnosis and treatment of thyroid disorders, underlying molecular mechanisms, and epidemiological studies, thereby bridging the gap between basic science and clinical practice. As an SCI-indexed publication, THYROID maintains a strong academic reputation and typically holds a position in the second or third quartile of the Chinese Academy of Sciences (CAS) journal ranking in the medical field, reflecting its significant impact factor and standing within the global scientific community. Although it operates primarily as a subscription-based journal, authors have the option to select open access for individual articles. Due to its rigorous standards and competitive acceptance process, the journal emphasizes the novelty of research and the rigor of methodology, often resulting in a thorough and potentially extended peer-review cycle. Consequently, THYROID remains an authoritative platform for researchers and clinicians seeking to disseminate impactful advancements in thyroid health and disease.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com